Quincy Toffler

Quincy Toffler is a distinguished author, specializing in uncovering the intricacies and impacts of emerging technologies. He earned his M.A. in Journalism and Media Studies from St. Xavier University, where he critically explored the confluence of technology, society, and media. Toffler honed his expertise during his tenure as a Technology Analyst with Northbridge Research Group, where he engaged in forward-thinking analysis on tech industry trends. Through his thoughtful and meticulous writing, Toffler strives to elucidate complex technologies, guide readers through rapid advancements, and reveal their implications on our future. His work serves not only as a resourceful overview of the modern tech landscape, but also as a profound exploration of our ever-evolving digital society.

Why Axsome Therapeutics’ Meteoric Rise May Be Just the Beginning

Why Axsome Therapeutics’ Meteoric Rise May Be Just the Beginning

Axsome Therapeutics stock has surged by 55% for the year, highlighting its unexpected market success. The company settled with Teva Pharmaceutical Industries, protecting its flagship drug, Auvelity, from generic competition until 2038. Axsome’s current product lineup includes Auvelity for depression, Sunosi for
16 February 2025
1 2 3 19